Figure 12 shows mean difference in percent HDL change from baseline to time point comparing mid potency combination therapy with ezetimibe to high potency monotherapy in patients with DM.

Figure 12Mean difference in percent HDL change from baseline to time point comparing mid potency combination therapy with ezetimibe to high potency monotherapy in patients with DM

ATV = atrovastatin; NR = not reported; SMV = simvastatin

Note: For diamonds without confidence intervals, SE/SD could not be calculated.

From: Results

Cover of Combination Therapy Versus Intensification of Statin Monotherapy: An Update
Combination Therapy Versus Intensification of Statin Monotherapy: An Update [Internet].
Comparative Effectiveness Reviews, No. 132.
Monroe AK, Gudzune KA, Sharma R, et al.

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.